Briefs: Krsnaa Diagnostics

Krsnaa Diagnostics has commenced its fourth out of eight Diagnostics Center in Ayodhya

Formosa Pharmaceuticals and AimMax Therapeutics announce NDA Submission to USFDA for APP13007

APP13007 is a novel aqueous nanosuspension formulation for the treatment of inflammation and pain following ocular surgery

Galmed Pharmaceuticals forms partnership with OnKai

Both the companies intend to facilitate faster clinical trial enrollment and provide patients with access to novel medications

Wacker acquires Spain-based biotech firm ADL BioPharma

The acquisition of ADL BioPharma now makes WACKER owner of the entire plant, with total fermentation capacities of just under 3,000 cubic meters

Lupin to acquire French pharmaceutical company Medisol

The acquisition of Medisol is part of Lupin's strategy to expand its presence in the EU

Zydus receives final approval from the USFDA for Sucralfate Tablets USP, 1 gram

Brain Cells are starved of energy when autophagy malfunctions: New Study

The Research by Indian Fellow at the University has major implications for neurodegenerative disease treatments

India is emerging as a favourable destination to conduct clinical trials: PwC-USAIC Report

Biopharma can benefit from the critical enablers of innovation in the private healthcare system in India

Hyderabad startup’s Physiotherapy monitoring device ‘Pheezee’ receives USFDA

Pheezee is designed to assess musculoskeletal and neuromuscular health.

PredOmix launches campaign for free cancer screening

PredOmix has developed a novel blood test that can detect about 32 cancers in both men and women with 98 percent accuracy